Bristol Myers Squibb has added a familiar face to an ongoing initiative to thank oncologists for the valuable time they ...
Sandoz has struck a deal with Samsung Bioepis to partner on up to five biosimilars, with the first being SB36, a copycat of ...
Johnson & Johnson and Protagonist Therapeutics are countering the swarm of injectable biologics that have long dominated the ...
As interest in the cancer-fighting potential of radiopharmaceutical drugs continues to swell, companies have unleashed a ...
Much of President Donald Trump’s campaign promises to lower drug prices in the U.S. | According to a review by The New York ...
Since investment bank HSBC downgraded the stock of Eli Lilly from “hold” to “reduce” on Tuesday morning, the share price of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results